Teva Pharmaceutical Industries Ltd (NYSE: TEVA)
| Last Price | $16.49 |
| Net Change | $-0.52 (-3.06%) |
| Bid | $16.51 |
| Ask Price | $16.53 |
| Open Price | $17.01 |
| Previous Close Price | $17.01 |
| High Price | $17.02 |
| Low Price | $16.45 |
| Number of Trades | 63,793 |
| Volume | 19,955,537 |
| Fifty Two Week High | $53.96 (2016-08-24) |
| Fifty Two Week Low | $16.45 (2017-08-23) |
| Average Daily Volume | 11,624,392 |
| Share Outstanding | 1,016,000 Shares |
| Total Dividend Payout | 0.87/yr |
| Dividend Yield | 5.09% |
| 1st Quarter Earnings | $1.02 (2017-08-03) |
| 2nd Quarter Earnings | $1.06 (2017-05-11) |
| 3nd Quarter Earnings | $1.38 (2017-02-13) |
| 4th Quarter Earnings | $1.31 (2016-11-15) |
| PE Ratio | $3.66 |
| EPS Growth | $-17.11 |
| Recent Earnings | $1.02 |
| Annual EPS | $4.66 |
| Last Quarter EPS | $ |
| Market Capitalization | $17.28B |
| Insider Shareholders % | 0.071% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 1,016,000 |
| Inst. Shareholder % | 56.04% |
| Annual Net Income | $-5.89B |
| TTM Net Profit Margin | $-25.19 |
| 1-Year Return | -68.03% |
| 3-Year Return | -67.43% |
| 5-Year Return | -57.91% |
| 5-Year Revenue Growth | 19.61% |
| 5-Year Earnings Growth | 1.81% |
| 5-Year Dividend Growth | 48.72% |
| Annual Dividend | $0.87 |
| Annual Dividend Yield | 5.09% |
| Change in EPS YTD | -17.110001% |
| Dividends per Share | $0.289 |
| Stock Split Ratio | 2-1 |
| Beta | 0.46 |
TEVA News & Stock Updates
August 4, 2017
3 of the Top Pharmaceutical Stocks to Buy NowJuly 6, 2017
3 Biotech Stocks to Buy Now for Up to 270% GrowthJune 6, 2017
The 3 Best Pharmaceutical Stocks to Buy in 2017June 1, 2017
How Mylan Stole $1.27 Billion from Taxpayers and Rewarded Its Top ExecsApril 20, 2017
Why Indian Startups Are Targeting This New $5 Billion Market